STOCKHOLM, Feb. 11, 2022 /PRNewswire/ — Implantica AG (publ), an rising and rapidly expanding med-tech corporation that is revolutionary ground breaking answers to deal with continual health conditions with intelligent implants, announces the effective completion of a 3-working day eHealth workshop to progress the usability of our exclusive eHealth system know-how.
20 industry experts from all above Europe participated in this intensive seminar. The sessions offered a far more complete understanding of the use situations in the course of the existence cycle of phases of the implant from manufacture to the diverse treatment phases until eventually conclude-of-cure.
“Implantica’s skilled crew held a incredibly productive eHealth usability workshop on our eHealth system. With Implantica’s new platform, it will be feasible to adjust sophisticated treatment on length, which will bring a whole landmark in the growth of new wise implanted eHealth-dependent health-related treatments and thus preserve fees for culture. I would like to get this chance to thank all individuals for a constructive 3 times,” said Peter Forsell, CEO of Implantica.
For even more information and facts, please call:
Nicole Pehrsson, Trader Relations
Telephone (CH): +41 ()79 335 09 49
Implantica is listed on Nasdaq 1st North Leading Progress Current market in Stockholm.
The company’s Qualified Adviser is FNCA Sweden AB, +46 ()8 528 00 399, [email protected]
The details was despatched for publication, via the company of the call man or woman established out over, on February 11, 2022 at 08:30 a.m. CET.
Implantica is a medtech business committed to bringing sophisticated know-how into the entire body. Implantica’s direct product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially develop a paradigm shift in anti-reflux treatment method as supported by successful clinical demo outcomes. Implantica also focuses on eHealth inside of the body and has formulated a wide, patent safeguarded, product or service pipeline based partly on two platform systems: an eHealth system built to keep track of a broad variety of wellness parameters, control therapy from inside of the entire body and communicate to the caregiver on distance and a wi-fi energising system developed to electric power distant managed implants wirelessly by intact pores and skin. Implantica is mentioned on Nasdaq 1st North Leading Development Market place (ticker: IMP A SDB). Check out www.implantica.com for even more information.
This info was brought to you by Cision http://information.cision.com
The pursuing files are out there for down load: